Screening for NAFLD in Flanders

NCT04647409 | Active Not Recruiting

• 1 other identifier: SCREEFLAN-01
• Study Type: interventional
• Target: 10,000
• Locations: 1 country
• Sites: 1

Brief Summary

In the Belgian adult population more than half, and numbers are still increasing, of the population is overweight or obese. These people are at risk to develop NAFLD. However, we lack epidemiological data in Belgium. Therefore, it is important to do epidemiological studies to investigate NAFLD prevalence and disease severity based on a non-invasive approach and evaluate how patients are to be referred.

Conditions

Non-Alcoholic Fatty Liver Disease

Outcome Measures

Primary Outcomes (2)

• CLDQ-NAFLD

  The determination of the prevalence of NAFLD in a general population in Flanders, Belgium by using A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

  baseline

• 36-Item Short Form Survey (SF-36)

  SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting and are now widely utilized by managed care organizations and by Medicare for routine monitoring and assessment of care outcomes in adult patients.

  baseline

Study Arms (1)

participants

OTHER

Other: screening

Interventions

screening OTHER

The determination of the prevalence of NAFLD in a general population in Flanders, Belgium

participants

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years or older,
• able to understand Dutch,
• able to understand the informed consent

You may not qualify if:

• secondary causes of steatosis
• excessive alcohol abuse

Sponsors & Collaborators

• Hasselt University: lead

Study Sites (1)

Hasselt University

Hasselt, 3500, Belgium

Location

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

Mass Screening

Condition Hierarchy (Ancestors)

Fatty Liver; Liver Diseases; Digestive System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and Procedures; Diagnosis; Health Surveys; Surveys and Questionnaires; Data Collection; Epidemiologic Methods; Investigative Techniques; Diagnostic Services; Preventive Health Services; Health Services; Health Care Facilities Workforce and Services; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health; Public Health Practice

Study Officials

• Geert Robaeys, prof. dr.

  Hasselt University

  PRINCIPAL INVESTIGATOR

• Leen Heyens, drs.

  Hasselt University

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SCREENING
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: November 26, 2020
• First Posted: November 30, 2020
• Study Start: October 26, 2020
• Primary Completion: April 30, 2025
• Study Completion (Estimated): December 31, 2026
• Last Updated: December 1, 2025

Record last verified: 2025-11

Locations

BE (1)